“…Moreover, PAL has been successfully used in identification of AD, at various stages of the disease, including very early stages (e.g., Sahakian et al., 1988, Swainson et al., 2001; see also (Barnett, Blackwell, Sahakian, & Robbins, 2016) for a complete review about PAL findings). Finally, the number of errors across all attempts during PAL has recently been shown to correlate with the available biomarkers of AD in a sample of patients with MCI, i.e., CSF levels of tau, P-tau, Ab42, and hippocampal volumes (Nathan, Lim, Abbott, Galuzzi, Marizzoni, Babiloni et al., 2017), strongly arguing for the use of that task to identify hippocampal abnormalities in the context of early AD.…”